KGWV · U.S. MARKET INTELLIGENCE
Latest close on July 31, 2026: $123.06 (+0.7% on the latest daily bar). HMA21 / HMA55: $122.85 / $126.59. 200DMA: $152.89. Relative volume: 0.81x the 20-day average. Latest comparable filing period: 2026 Q1 ending 2026-03-31; filed 2026-05-05. Comparable growt…
Focus: Second-quarter 2026 earnings from U.S.-listed companies. The global race to build AI data centers is significantly boosting chipmakers’ results, with memory-chip prices rising particularly sharply. Kioxia, a Japanese chipmaker, said Friday that strong d…
A tax-gain-harvesting strategy described by the source involves selling profitable holdings at a 0% federal tax rate and immediately buying back the same shares to reset their cost basis permanently. Section 1091 of the U.S. Internal Revenue Code applies the w…
Novo Nordisk said a late-stage clinical trial of its heart-disease drug ziltivekimab failed to show that the treatment was more effective than a placebo at reducing major adverse cardiovascular events. The company's shares subsequently fell as much as 10%.
South Korea’s KOSPI fell 1,881.03 points, or 22.19%, this month to close at 6,595.45. It posted its largest one-month percentage decline since October 2008, ending a three-month winning streak. The index fell 95.17 points, or 1.42%, this week. It has dropped 2…
Eurostat said Friday that annual consumer-price inflation in the euro area’s 21 countries rose to 2.9% in July from 2.8% in June. The reading was slightly above the 2.8% rate broadly expected by economists surveyed by the media. Energy inflation, which cooled…
Canadian oil and gas infrastructure company Enbridge said it remains positioned for growth despite a difficult macroeconomic environment. The company reported second-quarter profit of C$1.4 billion, or about US$1 billion, equal to C$0.64 per share. That was do…
Moderna shares fell more than 2% in premarket trading Friday after the biotechnology company reported second-quarter results and lowered some of its full-year financial forecasts. The vaccine maker reported earnings of $1.97 per share, below the $2.03-per-shar…
Cleveland Federal Reserve President Beth Hammack has been a staunch advocate of raising interest rates to contain inflation. This week, three Federal Reserve policymakers who voted against the central bank's decision said they feared inflation would become ent…
AbbVie lowered its full-year adjusted earnings outlook to reflect its acquisition of Apogee Therapeutics, even as the pharmaceutical company reported higher profit and revenue for the latest quarter. The company said Friday that the proposed acquisition is exp…